Mortality among tuberculosis patients in the Democratic Republic of Congo

The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
C HenegarAnnelies Van Rie

Abstract

Kinshasa, Democratic Republic of Congo. To identify programmatic interventions for improved survival in patients receiving treatment for tuberculosis (TB) at primary care clinics. Retrospective cohort of adult patients initiating anti-tuberculosis treatment between January 2006 and May 2007. Among 5685 patients, 390 deaths occurred during anti-tuberculosis treatment, of which half (52%) did so during the first 2 months. Patients with smear-negative pulmonary TB were at greater risk of death in the first 2 months of treatment (human immunodeficiency virus [HIV] positive HR 1.49, 95%CI 0.89-2.49; HIV-negative HR 1.77 95%CI 1.06-2.95), but not thereafter. Patients with extra-pulmonary TB were at increased risk of death in the first 2 months of anti-tuberculosis treatment if they were non-HIV-infected (HR 2.42, 95%CI 1.52-3.85), and were half as likely to die during the remainder of treatment (HIV-positive HR 0.46, 95%CI 0.22-0.97; HIV-negative HR 0.47, 95%CI 0.23-0.94). Antiretroviral therapy (ART) reduced the risk of death by an estimated 36% (HR 0.64, 95%CI 0.37-1.11). High mortality in the first months of anti-tuberculosis treatment could be reduced by addressing diagnostic delays, particularly for extra-pulmonary and smear-neg...Continue Reading

Citations

Oct 5, 2013·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Annelies Van RieFrieda Behets
Nov 13, 2013·Transactions of the Royal Society of Tropical Medicine and Hygiene·Serge AdeSévérin Anagonou
Feb 2, 2021·International Journal of General Medicine·Peize ZhangGuofang Deng

Related Concepts

Related Feeds

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Related Papers

The New England Journal of Medicine
Salim S Abdool KarimQuarraisha Abdool Karim
American Journal of Respiratory and Critical Care Medicine
Christina GreenawayCanadian Collaborative Group in nosocomial Transmission of Tuberculosis
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
T ShimazakiM Suzuki
© 2021 Meta ULC. All rights reserved